125. The 5-HT hypothesis of depression with Prof Philip Cowen and Dr Sameer Jauhar

·33 min·1 clip

They didn't analyze any data—they just cherry-picked conclusions

Depression is not a one-molecule story. The episode starts with shared psychopharmacology history, as David Nutt places the guests in an argument about antidepressant action, science, and psychiatry. Serotonin is the pressure point, but nobody gets to hide behind a cartoon version of it. The guests explain why severe depression, drug effects, and neurochemistry still matter even when the old chemical imbalance line is too thin. The talk is blunt in places. Nutt says the three were horrified by the quality of one analysis and bored by its conclusions, then asks what the scientific reply actually achieved. One guest talks about the work behind that reply: over 30 people, including authors of original reviews, agreed to focus on clear methodological errors instead of turning it into a fight about emotion. Molecular Psychiatry is part of the story because it published the original paper, the expert letter, and a response from the authors that the guest says added more mistakes. The episode does not tie the problem up neatly. One guest argues for more research into serotonin's role in severe depression, while also leaving room for social causes. By the end, the discussion has moved into socioeconomic deprivation and the false split between social determinants and neurochemistry. Social conditions change the brain. Brain states shape how illness develops, hangs around, and responds to treatment. Nutt compares it to heart disease: deprivation can be a major risk factor without making every case purely social or every biological account complete. The mood is sober, not defensive. It asks listeners to hold bad evidence, real suffering, and imperfect treatments together without reaching for a slogan.

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from The Drug Science Podcast